Mr. Aditya Kumar Halwasiya outlines FY27 guidance of ₹725–750 crore revenue and ₹210–225 crore net profit; highlights consumer growth, Palava capacity expansion, global healthcare opportunities
Tag: South Africa
TB Alliance ZeNix trial Show Effectiveness of BPaL Regimen for Highly Drug-Resistant TB
ZeNix trial in South Africa and Eastern Europe sought to optimize the 6-month treatment regimen with reduced exposure to the drug linezolid India has the